Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the post-licensure rapid immunization safety monitoring (PRISM) system, 2009-2010

American Journal of Epidemiology

Volumn 175, Issue 11, 2012, Pages 1120-1128

  Yih, W Katherine ^a   Lee, Grace M ^a,b   Lieu, Tracy A ^a   Ball, Robert ^c   Kulldorff, Martin ^a   Rett, Melisa ^a   Wahl, Peter M ^d   McMahill Walraven, Cheryl N ^e   Platt, Richard ^a   Salmon, Daniel A ^f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d HEALTHCORE INC   (United States)

^e AETNA   (United States)

^f U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

Guillain Barr syndrome; H1N1 subtype; influenza A virus; influenza vaccines; population surveillance; safety; vaccines

Indexed keywords

INFLUENZA VACCINE;

COHORT ANALYSIS; DISEASE INCIDENCE; EPIDEMIOLOGY; HEALTH AND SAFETY; HEALTH INSURANCE; IMMUNIZATION; INFLUENZA; MONITORING SYSTEM; RISK ASSESSMENT; VACCINATION; VACCINE;

2009 H1N1 INFLUENZA; ALLERGIC REACTION; ANAPHYLAXIS; ARTICLE; ATAXIA; BELL PALSY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CRANIAL NEUROPATHY; DATA PROCESSING; DEMYELINATING DISEASE; DISEASE REGISTRY; DRUG SURVEILLANCE PROGRAM; ENCEPHALITIS; ENCEPHALOMYELITIS; GROUPS BY AGE; GUILLAIN BARRE SYNDROME; HEALTH CARE PLANNING; HEALTH INSURANCE; HUMAN; INFECTION CONTROL; INFLUENZA VACCINATION; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICAL RECORD REVIEW; MYELITIS; OUTCOME ASSESSMENT; PANDEMIC INFLUENZA; PERIPHERAL NEUROPATHY; POST LICENSURE RAPID IMMUNIZATION SAFETY MONITORING; RISK ASSESSMENT; SEIZURE; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; COHORT STUDIES; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; INCIDENCE; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; LOGISTIC MODELS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PRODUCT SURVEILLANCE, POSTMARKETING; RETROSPECTIVE STUDIES; RISK ASSESSMENT; UNITED STATES; UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES; VACCINES, ATTENUATED; VACCINES, INACTIVATED; YOUNG ADULT;

UNITED STATES;

INFLUENZA A VIRUS;

EID: 84862197906     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws197     Document Type: Article

References (22)

1. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol. 1979;110(2):105-123. (Pubitemid 10209694)
2. Salmon DA, Akhtar A, Mergler MJ, et al. Immunization safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program. Pediatrics. 2011;127(suppl 1): S78-S86.
3. Lieu TA, Kulldorff M, Davis RL, et al. Real-time vaccine safety surveillance for the early detection of adverse events. Med Care. 2007;45(10 suppl 2):S89-S95.
4. Kulldorff M, Davis RL, Kolczak M, et al. A maximized sequential probability ratio test for drug and vaccine safety surveillance. Seq Anal. 2011;30(1):58-78.
5. Li L, Kulldorff M. A conditional maximized sequential probability ratio test for pharmacovigilance. Stat Med. 2010;29(2): 284-295.
6. Lee GM, Greene SK, Weintraub ES, et al. H1N1 and seasonal influenza vaccine safety in the Vaccine Safety Datalink Project. Am J Prev Med. 2011;41(2):121-128.
7. Greene SK, Kulldorff M, Lewis EM, et al. Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. Am J Epidemiol. 2010; 171(2):177-188.
8. Greene SK, Kulldorff M, Yin R, et al. Near real-time vaccine safety surveillance with partially accrued data. Pharmacoepidemiol Drug Saf. 2011;20(6):583-590.
9. Maro JC, Platt R, Holmes JH, et al. Design of a national distributed health data network. Ann Intern Med. 2009;151(5): 341-344.
10. Brown JS, Holmes JH, Shah K, et al. Distributed health data networks: a practical and preferred approach to multi-institutional evaluations of comparative effectiveness, safety, and quality of care. Med Care. 2010;48(6 suppl): S45-S51.
11. Sejvar JJ, Kohl KS, Gidudu J, et al. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29(3):599-612.
12. Kramarz P, DeStefano F, Gargiullo PM, et al. Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Arch Fam Med. 2000;9(7): 617-623.
13. Klein NP, Hansen J, Lewis E, et al. Post-marketing safety evaluation of a tetanus toxoid, reduced diphtheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in a United States health maintenance organization. Pediatr Infect Dis J. 2010;29(7):613-617.
14. Fireman B, Lee J, Lewis N, et al. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol. 2009;170(5):650-656.
15. Greene SK, Rett M, Weintraub ES, et al. Risk of confirmed Guillain-Barré syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010. Am J Epidemiol. 2012; 157(11): 1100-1109.
16. Kulldorff M, Nagarwalla N. Spatial disease clusters: detection and inference. Stat Med. 1995;14(8):799-810.
17. Centers for Disease Control and Prevention. Final Estimates for 2009-10 Seasonal Influenza and Influenza A (H1N1) 2009 Monovalent Vaccination Coverage-United States, August 2009 Through May, 2010. Atlanta, GA: Centers for Disease Control and Prevention; 2011. (http://www.cdc.gov/flu/professionals/ vaccination/coverage-0910estimates.htm). (Accessed December 21, 2011).
18. McGrogan A, Madle GC, Seaman HE, et al. The epidemiology of Guillain-Barré syndrome worldwide: a systematic literature review. Neuroepidemiology. 2009;32(2):150-163.
19. Dieleman J, Romio S, Johansen K, et al. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ. 2011;343:d3908. (doi:10.1136/bmj.d3908).
20. Grimaldi-Bensouda L, Alpérovitch A, Besson G, et al. Guillain-Barré syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. Am J Epidemiol. 2011;174(3):326-335.
21. Campbell KE, Brundage JF. Effects of climate, latitude, and season on the incidence of Bell's palsy in the US Armed Forces, October 1997 to September 1999. Am J Epidemiol. 2002;156(1): 32-39. (Pubitemid 34680621)
22. Food and Drug Administration, US Department of Health and Human Services. Highlights of Prescribing Information for Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal. Washington, DC: Food and Drug Administration; 2009. (http://www.fda.gov/downloads/biologicsbloodvaccines/vaccines/approvedproducts/ ucm182406.pdf). (Accessed November 29, 2011).